Additionally, the study showed that NLRP3-mediated inflammatory pathways play a critical role in atherosclerosis progression, placing the possibility of specific NLRP3 inhibitors as promising therapies to combat atherosclerosis. This evidence concerns the gene NLRP3 and atherosclerosis.